Dr. Stefan Bohnenberger

Dr. Stefan Bohnenberger is a seasoned professional in business development within the clinical research sector, currently serving as Senior Director of Business Development at Allucent since February 2021. Previously, Dr. Bohnenberger held senior leadership roles at Covance, where responsibilities included business development for clinical development across Europe from May 2018 to February 2021, and at Clinipace Worldwide, overseeing business development in Europe and the Middle East from July 2015 to April 2018. Additional experience includes positions at inVentiv Health Clinical, Accovion GmbH, and Quintiles, with a career beginning at Novo Nordisk as a Trainee Clinical Research in 2004. Dr. Bohnenberger holds two doctoral degrees in Toxicology and Biology/Chemistry from TU Kaiserslautern and RPTU Kaiserslautern-Landau, respectively.